Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry

Serna-Higuita, Lina Maria; Amaral, Teresa; Forschner, Andrea; Leiter, Ulrike; Flatz, Lukas; Seeber, Olivia; Thomas, Ioannis; Garbe, Claus; Eigentler, Thomas Kurt; Martus, Peter

dc.contributor.author	Amaral, Teresa
dc.contributor.author	Flatz, Lukas
dc.contributor.author	Thomas, Ioannis
dc.contributor.author	Garbe, Claus
dc.contributor.author	Eigentler, Thomas
dc.contributor.author	Martus, Peter
dc.contributor.author	Serna Higuita, Lina María
dc.contributor.author	Forschner, Andrea Lydia
dc.contributor.author	Leiter-Stöppke, Ulrike
dc.contributor.author	Seeber, Tonia Olivia
dc.date.accessioned	2022-05-30T07:32:21Z
dc.date.available	2022-05-30T07:32:21Z
dc.date.issued	2021
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10900/127499
dc.language.iso	en	de_DE
dc.publisher	Basel	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/cancers13236141	de_DE
dc.subject.ddc	610	de_DE
dc.title	Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220404000000_00352
utue.personen.roh	Serna-Higuita, Lina Maria
utue.personen.roh	Amaral, Teresa
utue.personen.roh	Forschner, Andrea
utue.personen.roh	Leiter, Ulrike
utue.personen.roh	Flatz, Lukas
utue.personen.roh	Seeber, Olivia
utue.personen.roh	Thomas, Ioannis
utue.personen.roh	Garbe, Claus
utue.personen.roh	Eigentler, Thomas Kurt
utue.personen.roh	Martus, Peter
dcterms.isPartOf.ZSTitelID	Cancers	de_DE
dcterms.isPartOf.ZS-Issue	Article 6141	de_DE
dcterms.isPartOf.ZS-Volume	13 (23)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE